Supplementary Materials Expanded View Figures PDF EMBJ-36-2510-s001
Kurt Nichols on Supplementary Materials Expanded View Figures PDF EMBJ-36-2510-s001. by a two\tailed impartial experiments. Statistical significance, as determined by a two\tailed impartial experiments. Statistical significance, as determined by a two\tailed phenotype induced by the Skp2 and p27 double mutant with respect to cell proliferation (Kossatz impartial experiments. The significance, as determined by a two\tailed (Lien impartial experiments. The significance, as determined by a two\tailed BETd-260 impartial experiments. The YAP\Skp2 axis does not seem to be conserved in mice Although we originally planned to study this phenomenon using a mouse model, we speculated that this YAP\Skp2 axis may not be conserved in mice for several reasons. First, activated YAP does not up\regulate Skp2 in various mouse cell lines or in Lats1/2 dKO MEF despite the induction of Ctgf, an established YAP target gene (Fig?7A and B). Second, although depletion of Yap in murine mammary cell lines reduces Skp2 protein levels (Fig?7C), comparable to what was observed in human cell lines (Fig?1E), this may be an indirect consequence of the enrichment of cells in G0/G1 that is induced by Yap depletion. This enrichment is usually reflected BETd-260 in reduced levels of cyclin B1 observed in Yap\depleted cells. Indeed, unlike in human cell lines (Figs?1G and ?and7D,7D, left), Skp2 levels in Yap\depleted 4T1 mitotic cells collected using the method used for Fig?1G were comparable to the Skp2 levels of control knockdown or mock mitotic cells (Fig?7D, right). This was not the case for Ctgf levels. BETd-260 Importantly, MG132\mediated inhibition of the proteasome in Yap\depleted 4T1 cells rescues Skp2 protein levels (Fig?7E). This suggests the reduction in Skp2 we observed in Yap\depleted 4T1 mouse cells may be attributed to the APC\Cdh1\mediated proteasomal degradation that usually occurs during early G1 phase. Of note, MG132 treatment does not rescue the reduction in Skp2 induced by YAP knockdown in human cell lines (Figs?1F and EV1A). Third, in contrast to what we FGF10 observed with human cells (Fig?2I), Skp2 expression is reduced in 5SA\YAP\expressing mouse cells grown in suspension (Fig?7F). Fourth, despite significant similarity in the Skp2 promoter upstream of its TSS between human and mouse, there is little similarity downstream of the TSS. Importantly, the mouse Skp2 promoter has no TEAD\binding consensus site corresponding to TB2 in the human Skp2 promoter (Fig?7G). Compared to other mammals, the mouse Skp2 promoter also contains relatively few TEAD\binding motifs around the TSS (Fig?7H). Fifth, 5SA\YAP expression up\regulates Skp2 expression in canine cells (MDCK), which have the conserved TB2 region (Fig?7G and I). Finally, we surveyed the microarray data generated from transgenic YAP mouse liver (Dong for 20?mins to clear debris and then supplemented with 6?g/ml polybrene (Sigma) to improve target cell contamination. One day after contamination, the infected cells were selected for 2C3?days using 3?g/ml puromycin or 250?g/ml hygromycin. For lentiviral particle production, 293T cells were transfected with BETd-260 a 4:3.5:0.5 ratio of DNA pLVX vector:delta 8.2:VSVG using PEI?and?packaged with the retroviral packaging protocol described above. All shRNAs used in this study were cloned into the lentiviral pLKO.1 puro plasmid. The shRNA target sequences we used, which?were previously validated (Chan and the supernatants were collected. Protein concentration was measured using.